Stock Screener App

無料 -

インストール

4.0494

1.49% 0.0594

Artiva Biotherapeutics Inc (ARTV)

概要ニュース株価時系列ディスカッション予測

Artiva Biotherapeutics Inc (ARTV) 最新ニュース

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $19.00 Average PT from Brokerages - Defense World

ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Artiva Biotherapeutics executes RSU exchange for employees - MSN

Trading Action: Is Artiva Biotherapeutics Inc stock a good pick for beginnersJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn

Hedge Fund Bets: Is CFRPRB stock heavily shortedTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Decline in Short Interest - MarketBeat

Pharma News: Can AGMH outperform under higher oil pricesTrade Exit Report & Technical Entry and Exit Tips - baoquankhu1.vn

Brokers Set Expectations for ARTV FY2030 Earnings - Defense World

Income Plays: Is Artiva Biotherapeutics Inc.’s ROE strong enoughJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - mfd.ru

Update Report: Can Artiva Biotherapeutics Inc. outperform in the next rallyJuly 2025 Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn

Undervalued Penny Stocks To Consider In January 2026 - simplywall.st

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY) - The Globe and Mail

Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Contin - The Globe and Mail

Artiva Biotherapeutics Announces Upcoming Presentations at - GlobeNewswire

Take Profit: Is Artiva Biotherapeutics Inc part of any ETF2025 Price Targets & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Aug Catalysts: How do insiders feel about Artiva Biotherapeutics IncJuly 2025 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Take Profit: Can Artiva Biotherapeutics Inc outperform in the next rallyWeekly Market Report & Daily Stock Trend Watchlist - baoquankhu1.vn

Wall Street Recap: Is AppTech Payments Corp Equity Warrant attractive for institutional investorsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn

Trend Recap: Will Artiva Biotherapeutics Inc outperform its industry peers2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn

Artiva Biotherapeutics Stock: Upcoming Data Presentations In Focus (NASDAQ:ARTV) - Seeking Alpha

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Growth in Short Interest - MarketBeat

Published on: 2026-01-14 12:03:58 - baoquankhu1.vn

Quarterly Trades: Will Artiva Biotherapeutics Inc. stock gain from lower inflationWeekly Profit Recap & AI Powered Trade Plan Recommendations - Bộ Nội Vụ

Valuation Update: Can Pineapple Financial Inc be recession proofQuarterly Investment Review & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Published on: 2026-01-14 05:34:55 - baoquankhu1.vn

Sjogren’s Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics - Barchart.com

Bearish Setup: Will EWCZ stock benefit from green energy trends2025 Price Targets & Accurate Entry and Exit Point Alerts - Bộ Nội Vụ

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN

Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Review & Low Drawdown Investment Strategies - ulpravda.ru

How Artiva Biotherapeutics Inc. stock performs in weak economyQuarterly Market Summary & Technical Entry and Exit Tips - Улправда

Is Artiva Biotherapeutics Inc. stock oversold or undervaluedQuarterly Risk Review & Growth Focused Investment Plans - ulpravda.ru

Is Artiva Biotherapeutics Inc. stock a good choice for value investorsOil Prices & Stepwise Swing Trade Plans - Улправда

How Artiva Biotherapeutics Inc. stock performs in high volatility marketsJuly 2025 Sentiment & Proven Capital Preservation Methods - Улправда

NanoSyrinx Appoints New CEO to Advance Nanosyringe Technology - Intellectia AI

Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3% – Should You Buy? - Defense World

Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3%Should You Buy? - MarketBeat

Artiva Biotherapeutics expands board with industry veteran - MSN

Genelux Corporation Announces Appointment of Jason Litten as Chief Medical Officer, Effective January 2, 2026 - marketscreener.com

New medical chief to guide late-stage trials for cancer immunotherapy - Stock Titan

Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO’s Latest Insider Share Sale - Yahoo Finance

Will Artiva Biotherapeutics Inc. stock deliver long term returnsMarket Risk Summary & Reliable Entry Point Alerts - Улправда

Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - MSN

Is Artiva Biotherapeutics Inc. stock undervalued vs historical averagesJuly 2025 PreEarnings & Technical Pattern Based Signals - DonanımHaber

Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) dropped from NASDAQ Biotechnology Index - marketscreener.com

CEO Moves: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Big Picture & High Accuracy Swing Entry Alerts - Улправда

Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда

Resistance Check: Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Safe Entry Trade Signal Reports - Улправда

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Artiva Biotherapeutics CEO sells $19,122 in stock By Investing.com - Investing.com Nigeria

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech

Insider Sell: Fred Aslan Sells Shares of Artiva Biotherapeutics Inc (ARTV) - GuruFocus

Insider Selling: Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells 3,187 Shares of Stock - MarketBeat

Artiva Biotherapeutics CEO sells $19,122 in stock - Investing.com

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

ROIV

$26.64

0.27%

RPRX

$45.51

1.73%

INCY

$101.92

1.14%

BNTX

$107.56

1.82%

INSM

$150.50

3.38%

ONC

$350.28

1.11%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く